Botulinum toxin type A injections in stiff knee gait.
- Conditions
- In the Netherlands live about 18.000 Cerebro Vascular Accident (CVA)-patients which discover problems with walking caused by insufficient footclearance. Causes of problems with the footclearance during the swing phase of gait are a combination of diminished dorsal flexion of the ankle, knee flexion and hip flexion. A diminished knee flexion during swing is defined a stiff knee gait. A stiff knee gait is often caused by an overactivity of the m. rectus femoris. Keywords: stroke, stiff knee gait
- Registration Number
- NL-OMON29171
- Lead Sponsor
- Roessingh Research and DevelopmentRoessinghsbleekweg 337577 AH Enschede
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 26
Inclusion Criteria
1. Age over 18 years;
2. 6 months post stroke;
Exclusion Criteria
1. Presence of other constraints in joints who impede walking;
2. Neurological problems not causes by a Cerebro Vascular Accident;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. VICON 3D analysis to determine knee flexion during swing phase;<br /><br>2. Electromyogram (EMG) measurements;<br /><br>3. BORG and VAS questionnaire for tonus;<br /><br>4. Duncan-Ely test;<br /><br>5. Kinematics (measured with VICON 3D gait analysis);<br /><br>6. Kinetics (measured with force plates);<br /><br>7. Muscle Activation in Pendulum, Passive and Active Movements Test (MAPPAM);<br /><br>8. Motricity Index;<br /><br>9. Rivermead Mobility Index;<br /><br>10. 6 minutes walk test;<br /><br>11. Timed Up and Go test.
- Secondary Outcome Measures
Name Time Method Stroke Impact Scale.